Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Short term Debt (2022 - 2024)

Gossamer Bio (GOSS) has 3 years of Short term Debt data on record, last reported at $9.6 million in Q1 2024.

  • For Q1 2024, Short term Debt fell 17.43% year-over-year to $9.6 million; the TTM value through Mar 2024 reached $9.6 million, down 17.43%, while the annual FY2023 figure was $11.6 million, 0.0% changed from the prior year.
  • Short term Debt reached $9.6 million in Q1 2024 per GOSS's latest filing, down from $11.6 million in the prior quarter.
  • Across five years, Short term Debt topped out at $11.6 million in Q4 2022 and bottomed at $9.6 million in Q1 2024.
  • Average Short term Debt over 3 years is $11.3 million, with a median of $11.6 million recorded in 2022.
  • Peak YoY movement for Short term Debt: changed 0.0% in 2023, then decreased 17.43% in 2024.
  • A 3-year view of Short term Debt shows it stood at $11.6 million in 2022, then changed by 0.0% to $11.6 million in 2023, then fell by 17.43% to $9.6 million in 2024.
  • Per Business Quant database, its latest 3 readings for Short term Debt were $9.6 million in Q1 2024, $11.6 million in Q4 2023, and $11.6 million in Q3 2023.